US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 2026202520242023
Class II · Moderate risk Terminated

Papaverine/Phent 5ml Mdv 30/0.5mg/Ml Inj

Reason Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Key Pharmacy and Compounding Center D-0729-2017
Class II · Moderate risk Terminated

Hydroxo-B12 5ml Pbf Mdv

Reason Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Key Pharmacy and Compounding Center D-0728-2017
Class II · Moderate risk Terminated

Hydroxo-B12 Pbf Mdv 10mg/Ml Inj

Reason Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Key Pharmacy and Compounding Center D-0727-2017
Class II · Moderate risk Terminated

Hydroxo-B12 30ml Pbf Mdv

Reason Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Key Pharmacy and Compounding Center D-0726-2017
Class II · Moderate risk Terminated

Hydroxo-B12 5ml Pbf Mdv 1mg/Ml Inj

Reason Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Key Pharmacy and Compounding Center D-0725-2017
Class II · Moderate risk Terminated

Hydroxo-B12 10ml Pbf Mdv 5mg/Ml Inj

Reason Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Key Pharmacy and Compounding Center D-0724-2017
Class II · Moderate risk Terminated

Hydroxo-B12 Inh Pf Gv 5mg/Ml Soln

Reason Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Key Pharmacy and Compounding Center D-0723-2017
Class II · Moderate risk Terminated

Hydroxo-B12 1ml Sdv 10mg/Ml Inj

Reason Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Key Pharmacy and Compounding Center D-0722-2017
Class II · Moderate risk Terminated

Hydroxo-B12 *1ml* Sdv 1mg/Ml Inj

Reason Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Key Pharmacy and Compounding Center D-0721-2017
Class II · Moderate risk Terminated

Hcg *10ml* Mdv 500u/Ml Inj

Reason Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Key Pharmacy and Compounding Center D-0720-2017
Class II · Moderate risk Terminated

Folinic Acid Mdv Inj

Reason Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Key Pharmacy and Compounding Center D-0719-2017
Class II · Moderate risk Terminated

Folinic Acid Mdv

Reason Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Key Pharmacy and Compounding Center D-0718-2017
Class II · Moderate risk Terminated

Folic Acid 1ml Sdv 10mg/Ml Inj

Reason Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Key Pharmacy and Compounding Center D-0717-2017
Class II · Moderate risk Terminated

Ferr Gluc/Procaine 10ml Mdv 60/10mg/Ml Inj

Reason Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Key Pharmacy and Compounding Center D-0716-2017
Class II · Moderate risk Terminated

Dmso 6.25% Ophth.

Reason Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Key Pharmacy and Compounding Center D-0715-2017
Class II · Moderate risk Terminated

Dmps Acid *5ml* Sdv 50mg/Ml Inj

Reason Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Key Pharmacy and Compounding Center D-0714-2017
Class II · Moderate risk Terminated

Co-Q-10 Oil 20ml Mdv

Reason Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Key Pharmacy and Compounding Center D-0713-2017
Class II · Moderate risk Terminated

Atropine Sulfate 0.5% Ophth

Reason Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Key Pharmacy and Compounding Center D-0712-2017
Class II · Moderate risk Terminated

Atropine Sulfate 0.01% Ophth

Reason Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Key Pharmacy and Compounding Center D-0711-2017
Class II · Moderate risk Terminated

5-Mthf Sdv 5mg/Ml Inj

Reason Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Key Pharmacy and Compounding Center D-0710-2017
Class II · Moderate risk Terminated

5-Mthf 10ml Sdv

Reason Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Key Pharmacy and Compounding Center D-0709-2017
Class II · Moderate risk Terminated

5-Mthf 10ml Mdv

Reason Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Key Pharmacy and Compounding Center D-0708-2017
Class II · Moderate risk Terminated

5-Mthf *10ml* Mdv 5mg/Ml Inj

Reason Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Key Pharmacy and Compounding Center D-0707-2017
Class II · Moderate risk Terminated

Riomet

Reason Microbial Contamination of Non-Sterile Products

Sun Pharmaceutical Industries, Inc. NDC 10631-206-01 D-0109-2018
Class II · Moderate risk Terminated

Estrone USP

Reason cGMP Deviations; lack of quality assurance.

American Pharmaceutical Ingredients LLC D-0919-2017